Gilead releases the results of a study with 312 people being treated with Remdesivir compared to 818 people of a similar group. They headline of a 62% decrease in fatality rate is impressive. 13 people being treated with the drug had died. If my math is not broken (as it is often) that means that 29 people would have died without the drug. With such a small sampling size the percentage range is one that I would take with a grain of salt. Just 3 people more that would have perished and fatality decrease would be less than 50%. I think I own some Gilead stock, so that part works out. And I thankful for everything that seems to work. I am just cautious about headlines that sound really good.